NIR Light-Driving Barrier-Free Group Rotation in Nanoparticles with an 88.3% Photothermal Conversion Efficiency for Photothermal Therapy.
Dongmei XiMing XiaoJianfang CaoLuyang ZhaoNing XuSaran LongJiangli FanKun ShaoWen SunXuehai YanXiaojun PengPublished in: Advanced materials (Deerfield Beach, Fla.) (2020)
Traditional photothermal therapy requires high-intensity laser excitation for cancer treatments due to the low photothermal conversion efficiency (PCE) of photothermal agents (PTAs). PTAs with ultra-high PCEs can decrease the required excited light intensity, which allows safe and efficient therapy in deep tissues. In this work, a PTA is synthesized with high PCE of 88.3% based on a BODIPY scaffold, by introducing a CF3 "barrier-free" rotor on the meso-position (tfm-BDP). In both the ground and excited state, the CF3 moiety in tfm-BDP has no energy barrier to rotation, allowing it to efficiently dissipate absorbed (NIR) photons as heat. Importantly, the barrier-free rotation of CF3 can be maintained after encapsulating tfm-BDP into polymeric nanoparticles (NPs). Thus, laser irradiation with safe intensity (0.3 W cm-2 , 808 nm) can lead to complete tumor ablation in tumor-bearing mice after intravenous injection of tfm-BDP NPs. This strategy of "barrier-free rotation" provides a new platform for future design of PTT agents for clinical cancer treatment.
Keyphrases
- high intensity
- photodynamic therapy
- drug release
- cystic fibrosis
- drug delivery
- cancer therapy
- resistance training
- fluorescent probe
- high throughput
- gene expression
- high speed
- adipose tissue
- papillary thyroid
- radiation therapy
- bone marrow
- squamous cell carcinoma
- stem cells
- energy transfer
- mesenchymal stem cells
- cell therapy
- lymph node metastasis
- young adults
- quantum dots
- radiation induced
- oxide nanoparticles